Oral BPC-157 Bioavailability: What the Science Actually Shows
No human pharmacokinetic study has ever measured oral BPC-157 blood levels. Here's what that means for the $150 capsules in your cabinet.
Independent Peptide Analysis
Evidence-based analysis, vendor accountability, and honest guidance in a market flooded with marketing claims. No vendor sponsorship. No pay-for-play reviews.
Finnrick Analytics has the largest public testing database. We dug into the aggregate patterns: purity rates, vendor tiers, and the price-quality correlation nobody talks about.
PDA is marketed as a distinct compound with FDA backing. The chemistry tells a different story.
$150 for 60 capsules containing roughly $10-25 in ingredients. What 80%+ gross margins tell you about the peptide supplement industry.
Letter grades for 12 oral BPC-157 vendors across transparency, testing, pricing, and regulatory compliance.
The biggest regulatory crackdown in peptide history. Who got hit, why, and what it means for the supply chain.
Oral BPC-157 vendors rated on transparency, third-party testing, value, and regulatory compliance. Updated quarterly.
Ratings reflect our independent analysis. Vendors cannot pay to improve their scores. See our methodology.
Evidence-rated profiles for every major peptide. What the research shows, what it doesn't, and what vendors won't tell you.
Weekly analysis of the peptide market: regulatory changes, vendor evaluations, research updates, and the news that matters. Zero vendor influence.